Developer docs
API playgroundTry for free, no card

Search company profiles

OncLive

Full company profile

uuid00083fo

Namestring
OncLive
Websiteurl
onclive.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

OncLive is a privately held, U.S.-based clinical oncology media and education company founded in 1999 and headquartered in Cranbury, New Jersey, with 51-100 employees. Its core product is a digital news and education platform (onclive.com and accompanying mobile app) that delivers oncology-focused editorial coverage, expert video conversations, clinical-trial reporting, and continuing medical education (CME/CE) content to oncologists, hematologists, and cancer researchers. The offering is organized around several interconnected sub-properties: the OncClub professional community, the Giants of Cancer Care awards program, the Luminary Awards in GI Cancers (co-presented with Georgetown University's Ruesch Center), Scientific Interchanges, the State of the Science Summit regional conferences, the National Fellows Forum for trainees, webinars, conference coverage and listings, peer-reviewed publications and supplements, interactive tools including the Biomarker Consortium for NSCLC, and a Consensus Viewpoints series.

The underlying technology stack is a content publishing and event-management platform rather than a technology product in the conventional sense: it combines a website, mobile app, CME/CE learning infrastructure, and recurring virtual/in-person event programming. No proprietary APIs, AI/ML models, or developer platform are exposed; the distribution channel is described as direct, enterprise-oriented, with global audience reach via the website and app.

Commercially, OncLive operates an event- and content-driven go-to-market targeting oncology professionals as its primary persona segment. Revenue mechanics are not publicly disclosed, but the only specifically identified revenue stream in the available data is recurring CME/CE education; events, sponsored publications, supplements, and dedicated conferences (Scientific Interchanges, State of the Science Summit) are the natural complementary monetization channels for a niche oncology publisher of this profile. No public pricing is disclosed, no parent company or institutional investor is identified, and ownership remains opaque in the source material.

Short descriptiontext

OncLive is a U.S. clinical oncology media and education company that provides oncology news, expert interviews, clinical trial coverage, CME/CE programs, conferences, and awards to practicing oncologists, hematologists, and cancer researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCranbury, United States
HQ citystring
Cranbury
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical oncology news, medical education, continuing medical education, oncology conferences, cancer expert insights
Industry2 codes
1Healthcare & Clinical Professional Development (CME/CE)
CodeEDAGANAJPrimaryYes
2Medical Oncology
CodeHLAKAFABPrimaryNo
NAICS code2 codes
  • Broadcasting and Content Providers516
  • Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers51621
SIC code1 code
  • Services-Health Services8000
Product category
Oncology Healthcare Professional Media and Education
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CME/CE Education
TypeSubscription Recurring
Description

Continuing medical education credits for healthcare professionals through structured learning programs

onclive.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

OncLive is a clinical oncology news and education platform that publishes oncology-focused articles, videos, expert interviews, podcasts, and conference coverage, and delivers accredited continuing medical education (CME/CE) programming and recognition programs for cancer care professionals. The platform operates a digital community (OncClub), hosts virtual and in-person events (Scientific Interchanges, State of the Science Summits, National Fellows Forum), and runs the Giants of Cancer Care and Luminary Awards in GI Cancers programs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

OncLive is a clinical oncology news platform providing comprehensive cancer expert insights through a portfolio of interconnected products. The core offering includes the main OncLive news platform (onclive.com), the OncClub professional community, and the Giants of Cancer Care awards program. The platform features content series including Expert Conversations, Shows & Podcasts, and Clinical Trials in Focus, alongside educational offerings such as CME/CE credits, Scientific Interchanges, State of the Science Summit regional conferences, National Fellows Forum, and Webinars. The company also publishes clinical oncology content through Publications and peer-reviewed Supplements. Additional resources include the OncLive mobile App, Interactive Tools, Consensus Viewpoints, and the Biomarker Consortium for NSCLC. The company also partners on specialized award programs like the Luminary Awards in GI Cancers with the Ruesch Center.

Product and service1 record
1OncLive Platform
Description

Clinical oncology news platform providing cancer expert insights, breaking news, clinical trial coverage, and professional education resources for oncology healthcare professionals.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-30
Description

OncLive partners with the Ruesch Center at Georgetown University to co-present the Luminary Awards in GI Cancers, recognizing individuals who have made significant contributions to gastrointestinal cancer research and patient outcomes. The awards ceremony is held annually at Georgetown University, with the 2025 ceremony scheduled for November 20, 2025.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Frontline Medical Communications' portfolio of specialty medical news sites with CME. Comparable business model of specialty HCP news + CME + conferences, with overlapping oncology and hematology audiences.

TypeDirect peer
Description

Digital medical education platform for healthcare professionals featuring audio/video content and CME. Comparable multi-format HCP education model with overlapping oncology content and similar distribution approach.

TypeDirect peer
Description

Oncology-focused medical education and decision-support platform offering CME-certified activities and expert-led content. Direct competitor in the oncology HCP education market with similar sponsor-funded model.

TypeBroad incumbent
Description

The dominant oncology professional society, operating ASCO Daily News, the Journal of Clinical Oncology, and annual meeting content. Overlaps OncLive in oncology news and CME, but with society-level content exclusivity and brand authority.

TypeDirect peer
Description

Daily medical news service for healthcare professionals with oncology coverage and CME offerings. Closely aligned HCP news + CME distribution model with overlapping professional audience.

TypeBroad incumbent
Description

Specialist healthcare publisher with oncology titles (e.g., Oncologist Practice) plus a wider medical media portfolio. Comparable specialist HCP media business but with broader therapeutic and geographic reach.

TypeBroad incumbent
Description

Major medical publisher producing oncology journals, CME, and educational programs as part of a much larger scientific publishing portfolio. Overlaps in oncology education but operates across many therapeutic areas.

TypeDirect peer
Description

WebMD's flagship professional medical news and CME platform reaching physicians across all specialties including oncology. Most directly comparable HCP-focused news + CME + virtual event portfolio with overlapping oncology audience.

TypeEmerging player
Description

Independent CME/CE provider focused heavily on oncology, hematology, and immunology. Direct competitor in accredited oncology medical education with similar pharma-funded business model.

TypeDirect peer
Description

Specialty-focused medical news, CME, and conference coverage publisher with strong oncology presence. Closest direct peer in terms of specialist HCP media, conference reporting, and CME/CE monetization model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OncLive

Oncology Healthcare Professional Media and Educationonclive.com

OncLive is a U.S. clinical oncology media and education company that provides oncology news, expert interviews, clinical trial coverage, CME/CE programs, conferences, and awards to practicing oncologists, hematologists, and cancer researchers.

What OncLive does

OncLive is a privately held, U.S.-based clinical oncology media and education company founded in 1999 and headquartered in Cranbury, New Jersey, with 51-100 employees. Its core product is a digital news and education platform (onclive.com and accompanying mobile app) that delivers oncology-focused editorial coverage, expert video conversations, clinical-trial reporting, and continuing medical education (CME/CE) content to oncologists, hematologists, and cancer researchers. The offering is organized around several interconnected sub-properties: the OncClub professional community, the Giants of Cancer Care awards program, the Luminary Awards in GI Cancers (co-presented with Georgetown University's Ruesch Center), Scientific Interchanges, the State of the Science Summit regional conferences, the National Fellows Forum for trainees, webinars, conference coverage and listings, peer-reviewed publications and supplements, interactive tools including the Biomarker Consortium for NSCLC, and a Consensus Viewpoints series.

The underlying technology stack is a content publishing and event-management platform rather than a technology product in the conventional sense: it combines a website, mobile app, CME/CE learning infrastructure, and recurring virtual/in-person event programming. No proprietary APIs, AI/ML models, or developer platform are exposed; the distribution channel is described as direct, enterprise-oriented, with global audience reach via the website and app.

Commercially, OncLive operates an event- and content-driven go-to-market targeting oncology professionals as its primary persona segment. Revenue mechanics are not publicly disclosed, but the only specifically identified revenue stream in the available data is recurring CME/CE education; events, sponsored publications, supplements, and dedicated conferences (Scientific Interchanges, State of the Science Summit) are the natural complementary monetization channels for a niche oncology publisher of this profile. No public pricing is disclosed, no parent company or institutional investor is identified, and ownership remains opaque in the source material.

OncLive firmographics

Firmographics
Name
OncLive
Website
https://onclive.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
OncLive is a U.S. clinical oncology media and education company that provides oncology news, expert interviews, clinical trial coverage, CME/CE programs, conferences, and awards to practicing oncologists, hematologists, and cancer researchers.
Ownership category
akta.pro rank

OncLive industry classification

Industry
Product category
Oncology Healthcare Professional Media and Education
NAICS
Broadcasting and Content Providers (516), Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (51621)
SIC
Services-Health Services (8000)
akta.pro primary industry
Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
akta.pro secondary industry
Medical Oncology (HLAKAFAB)

Keywords

  • Clinical oncology news
  • Medical education
  • Continuing medical education
  • Oncology conferences
  • Cancer expert insights

Where OncLive is headquartered

Location

Headquarters

HQ city
Cranbury
HQ country
United States
HQ region
North America

Markets served

OncLive business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. CME/CE Education: Continuing medical education credits for healthcare professionals through structured learning programs

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

OncLive product offering

Product offering

Core offering

OncLive is a clinical oncology news and education platform that publishes oncology-focused articles, videos, expert interviews, podcasts, and conference coverage, and delivers accredited continuing medical education (CME/CE) programming and recognition programs for cancer care professionals. The platform operates a digital community (OncClub), hosts virtual and in-person events (Scientific Interchanges, State of the Science Summits, National Fellows Forum), and runs the Giants of Cancer Care and Luminary Awards in GI Cancers programs.

Product overview

OncLive is a clinical oncology news platform providing comprehensive cancer expert insights through a portfolio of interconnected products. The core offering includes the main OncLive news platform (onclive.com), the OncClub professional community, and the Giants of Cancer Care awards program. The platform features content series including Expert Conversations, Shows & Podcasts, and Clinical Trials in Focus, alongside educational offerings such as CME/CE credits, Scientific Interchanges, State of the Science Summit regional conferences, National Fellows Forum, and Webinars. The company also publishes clinical oncology content through Publications and peer-reviewed Supplements. Additional resources include the OncLive mobile App, Interactive Tools, Consensus Viewpoints, and the Biomarker Consortium for NSCLC. The company also partners on specialized award programs like the Luminary Awards in GI Cancers with the Ruesch Center.

Differentiator

Problem solved

Functional benefit

Products and services

  • OncLive Platform Clinical oncology news platform providing cancer expert insights, breaking news, clinical trial coverage, and professional education resources for oncology healthcare professionals.

Companies that use OncLive

Customer profile

Segments1 record

Ideal customer profiles1 record

OncLive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

OncLive partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Ruesch Center for the Cure of Gastrointestinal CancerscoreStrategic or Co-development Partner · 30 October 2025OncLive partners with the Ruesch Center at Georgetown University to co-present the Luminary Awards in GI Cancers, recognizing individuals who have made significant contributions to gastrointestinal cancer research and patient outcomes. The awards ceremony is held annually at Georgetown University, with the 2025 ceremony scheduled for November 20, 2025.

Recent moves3 records

Expansion highlights4 records

OncLive competitors and assessment

Company assessment

Direct peers

  • MDedge: Frontline Medical Communications' portfolio of specialty medical news sites with CME. Comparable business model of specialty HCP news + CME + conferences, with overlapping oncology and hematology audiences.
  • ReachMD: Digital medical education platform for healthcare professionals featuring audio/video content and CME. Comparable multi-format HCP education model with overlapping oncology content and similar distribution approach.
  • Clinical Care Options (CCO): Oncology-focused medical education and decision-support platform offering CME-certified activities and expert-led content. Direct competitor in the oncology HCP education market with similar sponsor-funded model.
  • MedPage Today: Daily medical news service for healthcare professionals with oncology coverage and CME offerings. Closely aligned HCP news + CME distribution model with overlapping professional audience.
  • Medscape: WebMD's flagship professional medical news and CME platform reaching physicians across all specialties including oncology. Most directly comparable HCP-focused news + CME + virtual event portfolio with overlapping oncology audience.
  • Healio: Specialty-focused medical news, CME, and conference coverage publisher with strong oncology presence. Closest direct peer in terms of specialist HCP media, conference reporting, and CME/CE monetization model.

Broad incumbents

  • ASCO (American Society of Clinical Oncology): The dominant oncology professional society, operating ASCO Daily News, the Journal of Clinical Oncology, and annual meeting content. Overlaps OncLive in oncology news and CME, but with society-level content exclusivity and brand authority.
  • Haymarket Media: Specialist healthcare publisher with oncology titles (e.g., Oncologist Practice) plus a wider medical media portfolio. Comparable specialist HCP media business but with broader therapeutic and geographic reach.
  • Springer Healthcare / Adis: Major medical publisher producing oncology journals, CME, and educational programs as part of a much larger scientific publishing portfolio. Overlaps in oncology education but operates across many therapeutic areas.

Emerging players

  • PRIME Education: Independent CME/CE provider focused heavily on oncology, hematology, and immunology. Direct competitor in accredited oncology medical education with similar pharma-funded business model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

OncLive social profiles

Digital presence

OncLive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OncLive leadership team

Management profile

Number of profiles

OncLive funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OncLive M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OncLive

What does OncLive do?

OncLive is a clinical oncology news and education platform that publishes oncology-focused articles, videos, expert interviews, podcasts, and conference coverage, and delivers accredited continuing medical education (CME/CE) programming and recognition programs for cancer care professionals. The platform operates a digital community (OncClub), hosts virtual and in-person events (Scientific Interchanges, State of the Science Summits, National Fellows Forum), and runs the Giants of Cancer Care and Luminary Awards in GI Cancers programs.

Is OncLive a public or private company?

OncLive is a private company. It is classified as unknown and is currently operating.

When was OncLive founded?

OncLive was founded in 1999. It employs 51 to 100 people.

Where is OncLive based?

OncLive is headquartered in Cranbury, United States, in the North America region.

How does OncLive make money?

One revenue line is on record: CME/CE Education.

Who are OncLive's main competitors?

Direct peers on record are MDedge, ReachMD, Clinical Care Options (CCO), MedPage Today, Medscape and Healio. Broad incumbents are ASCO (American Society of Clinical Oncology), Haymarket Media and Springer Healthcare / Adis. PRIME Education is listed as an emerging player.

Does OncLive have an API?

No public API is recorded for OncLive.

What industry is OncLive in?

OncLive's product category is Oncology Healthcare Professional Media and Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 516 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
OncLiveRezatapopt For Locally Advanced or Metastatic Solid Tumors With a TP53 Y220C Mutation: Initial Analysis of the Pivotal PYNNACLE Phase 2 TrialThe article presents an initial analysis of the pivotal Phase 2 PYNNACLE trial evaluating rezatapopt, a first-in-class p53 reactivator, for patients with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. Alison Schram from Memorial Sloan Kettering Cancer Center discusses these early results in this OncLive report. The text serves as a summary of clinical data without detailing specific efficacy numbers or adverse event rates.GlobeNewswireOncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers announce recipients of the 2025 Luminary Awards in GI CancersOncLive and the Ruesch Center announced the 2025 Luminary Awards in GI Cancers, honoring Carolyn R. Aldigé, Katie Couric, Scott Kopetz, Anil Rustgi, and Margaret Tempero. The awards ceremony will be held on November 20, 2025, at Georgetown University's Riggs Library during the 16th Annual Ruesch Center Symposium.GlobeNewswireOncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers announce recipients of the 2025 Luminary Awards in GI CancersOncLive® and the Ruesch Center for the Cure of GI Cancers announced the winners of the 2025 Luminary Awards in GI Cancers, recognizing individuals who have contributed significantly to research and patient care. The awards ceremony will take place on November 20, 2025, at Georgetown University in Washington, D.C. The Ruesch Center is a leader in GI cancer treatment research and clinical trials, partnering annually with OncLive to honor outstanding contributions.GlobeNewswireGiants of Cancer Care® announces the 13th annual class of inducteesOncLive, Pfizer, DSI, and Regeneron announced the 13th annual Giants of Cancer Care inductees, selected by a committee of over 115 oncologists. The ceremony will be held on May 29, 2025, at the Adler Planetarium in Chicago, with inductees from categories including breast, gastrointestinal, and leukemia cancers.GlobeNewswireOncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers announce recipients of the 2024 Luminary Awards in GI CancersOncLive and the Ruesch Center announced the 2024 Luminary Awards in GI Cancers, honoring Anirban Maitra, Robert Mayer, Jeanne Ruesch, Lee E. Smith, and Richard Wender. The awards recognize their contributions to research and patient outcomes. An awards ceremony will be held on November 21, 2024, at The Westin Georgetown.GlobeNewswireMedNews Week and OncLive® forge partnership to advanceOncLive and MedNews Week announced a partnership to advance cancer care education and combat misinformation. The collaboration aims to provide audiences with current medical information and curated resources. New resources are added regularly to the partnership's library.GlobeNewswireOncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers Name Winners of the 2023 Luminary Awards in GI CancersOncLive and The Ruesch Center announced the five winners of the 2023 Luminary Awards in GI Cancers, including Monica M. Bertagnolli, Luis A. Diaz, Edith Peterson Mitchell, Rep. Donald M. Payne, and Martha Raymond. A reception honoring the awardees will be held on Nov. 16 at the Westin Georgetown in Washington, D.C.PR NewswireLa cofondatrice d'Agendia dans la huitième promotion annuelle des Giants of Cancer Care® d'OncLive®Agendia announced that its co-founder Laura van 't Veer has been selected as a 2020 Giants of Cancer Care® laureate by OncLive in the oncologic diagnostics category. The award recognizes her significant contributions to precision oncology, specifically regarding the development of the MammaPrint test for breast cancer.PR NewswireAgendia Co-Founder Named to Eighth Annual OncLive® Giants of Cancer Care® Class of InducteesAgendia, Inc co-founder and Chief Research Officer Laura van 't Veer was selected as the 2020 Cancer Diagnostics honoree for OncLive's Giants of Cancer Care award, chosen from 818 nominations. The virtual awards ceremony recognizing 15 oncology trailblazers took place on November 5, 2020, honoring individuals whose work has significantly impacted cancer patient care and research. Dr. van 't Veer's selection specifically recognizes her role in developing Agendia's MammaPrint genomic test for breast cancer recurrence.PR NewswireBonnie J. Addario Lung Cancer Foundation and OncLive Attack Lung Cancer with Lung Grant Tank Research FundingThe Bonnie J. Addario Lung Cancer Foundation (ALCF) and OncLive announced their first research grant collaboration called the 'Lung Grant Tank,' designed to provide young investigators with funding for lung cancer research over a one-year period. Ten semifinalists will be selected to present their grant proposals in person to a panel of experts, with mentorship from top cancer research opinion leaders prior to selection. Applications are due June 21, 2016, and winners will be announced at the PER 17th International Lung Cancer Congress in Huntington Beach, California, August 4-6, 2016.